GlassScriptPhysician profile
Mamon Y Maiteh
NPI 1699747899
$1,680.67
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,668 · 2020: $12.24.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $296.12 | 2019 | |
| Amgen INC. | $247.73 | 2019 | |
| Emd Serono, INC. | $129.89 | 2019 | |
| Genentech USA, INC. | $126.12 | 2019 | |
| Pfizer INC. | $125.67 | 2019 | |
| Csl Behring | $125.15 | 2019 | |
| Sunovion Pharmaceuticals INC. | $74.95 | 2019-2020 | |
| Lundbeck LLC | $61.23 | 2019 | |
| Acadia Pharmaceuticals INC | $51.87 | 2019 | |
| Ucb, INC. | $51.32 | 2019 | |
| Mallinckrodt Enterprises LLC | $46.52 | 2019 | |
| Acorda Therapeutics, INC | $43.25 | 2019 | |
| Genzyme Corporation | $40.30 | 2019 | |
| Eisai INC. | $37.92 | 2019 | |
| Allergan, INC. | $37.31 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tanabe Pharma America, INC. | $32.20 | 2019 | |
| Lilly USA, LLC | $27.49 | 2019 | |
| Supernus Pharmaceuticals, INC. | $26.53 | 2019 | |
| Biogen, INC. | $24.92 | 2019 | |
| Abbvie INC. | $22.85 | 2019 | |
| Ge Healthcare | $20.02 | 2019 | |
| Jazz Pharmaceuticals INC. | $16.61 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $14.70 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mamon Maiteh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.